Vital Healthcare Property Trust

NZSE:VHP Stock Report

Market Cap: NZ$1.3b

Vital Healthcare Property Trust Valuation

Is VHP undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of VHP when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Discounted Cash Flow
Simply Wall St
NZ$1.56
Fair Value
16.5% overvalued intrinsic discount
3
Number of Analysts

Below Fair Value: VHP (NZ$1.82) is trading above our estimate of fair value (NZ$1.56)

Significantly Below Fair Value: VHP is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for VHP?

Key metric: As VHP is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for VHP. This is calculated by dividing VHP's market cap by their current revenue.
What is VHP's PS Ratio?
PS Ratio7.2x
SalesNZ$171.08m
Market CapNZ$1.25b

Price to Sales Ratio vs Peers

How does VHP's PS Ratio compare to its peers?

The above table shows the PS ratio for VHP vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average6.8x
PFI Property For Industry
9.1x4.1%NZ$1.1b
KPG Kiwi Property Group
5.8x-1.4%NZ$1.5b
ARG Argosy Property
5.5x-1.7%NZ$851.5m
PCT Precinct Properties NZ & Precinct Properties Investments
6.8x-7.1%NZ$1.9b
VHP Vital Healthcare Property Trust
7.2x0.03%NZ$1.3b

Price-To-Sales vs Peers: VHP is expensive based on its Price-To-Sales Ratio (7.2x) compared to the peer average (6.8x).

Price to Sales Ratio vs Industry

How does VHP's PS Ratio compare vs other companies in the Global Health Care REITs Industry?

3 CompaniesPrice / SalesEstimated GrowthMarket Cap
VHP 7.2xIndustry Avg. 6.3xNo. of Companies6PS03.26.49.612.816+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: VHP is expensive based on its Price-To-Sales Ratio (7.2x) compared to the Global Health Care REITs industry average (6.3x).

Price to Sales Ratio vs Fair Ratio

What is VHP's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

VHP PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio7.2x
Fair PS Ratio11.6x

Price-To-Sales vs Fair Ratio: VHP is good value based on its Price-To-Sales Ratio (7.2x) compared to the estimated Fair Price-To-Sales Ratio (11.6x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst VHP forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentNZ$1.82
NZ$2.02
+11.0%
4.6%NZ$2.15NZ$1.95n/a3
Feb ’26NZ$1.88
NZ$2.03
+8.4%
4.1%NZ$2.15NZ$1.96n/a3
Jan ’26NZ$1.83
NZ$2.03
+11.1%
4.1%NZ$2.15NZ$1.96n/a3
Dec ’25NZ$1.86
NZ$2.03
+9.3%
4.1%NZ$2.15NZ$1.96n/a3
Nov ’25NZ$1.97
NZ$2.03
+3.2%
4.1%NZ$2.15NZ$1.96n/a3
Oct ’25NZ$1.84
NZ$2.03
+10.5%
4.1%NZ$2.15NZ$1.96n/a3
Sep ’25NZ$2.04
NZ$2.02
-0.8%
4.4%NZ$2.15NZ$1.96n/a3
Aug ’25NZ$1.93
NZ$2.08
+8.1%
3.1%NZ$2.17NZ$2.03n/a3
Jul ’25NZ$1.78
NZ$2.08
+17.2%
3.1%NZ$2.17NZ$2.03n/a3
Jun ’25NZ$1.92
NZ$2.12
+10.2%
6.2%NZ$2.30NZ$2.01n/a3
May ’25NZ$2.13
NZ$2.12
-0.6%
6.2%NZ$2.30NZ$2.01n/a3
Apr ’25NZ$2.23
NZ$2.12
-5.1%
6.2%NZ$2.30NZ$2.01n/a3
Mar ’25NZ$2.11
NZ$2.12
+0.6%
6.2%NZ$2.30NZ$2.01n/a3
Feb ’25NZ$2.22
NZ$2.15
-3.3%
5.5%NZ$2.30NZ$2.01NZ$1.883
Jan ’25NZ$2.21
NZ$2.15
-2.7%
7.2%NZ$2.35NZ$1.97NZ$1.833
Dec ’24NZ$2.10
NZ$2.19
+4.1%
5.4%NZ$2.35NZ$2.08NZ$1.863
Nov ’24NZ$1.95
NZ$2.19
+12.1%
5.4%NZ$2.35NZ$2.08NZ$1.973
Oct ’24NZ$2.12
NZ$2.24
+5.5%
8.4%NZ$2.50NZ$2.08NZ$1.843
Sep ’24NZ$2.24
NZ$2.25
+0.6%
9.4%NZ$2.55NZ$2.08NZ$2.043
Aug ’24NZ$2.35
NZ$2.37
+0.7%
8.6%NZ$2.62NZ$2.12NZ$1.933
Jul ’24NZ$2.34
NZ$2.39
+2.1%
7.3%NZ$2.62NZ$2.20NZ$1.783
Jun ’24NZ$2.29
NZ$2.38
+4.1%
6.9%NZ$2.60NZ$2.20NZ$1.923
May ’24NZ$2.33
NZ$2.38
+2.3%
6.9%NZ$2.60NZ$2.20NZ$2.133
Apr ’24NZ$2.34
NZ$2.39
+2.1%
6.6%NZ$2.60NZ$2.22NZ$2.233
Mar ’24NZ$2.42
NZ$2.44
+1.0%
9.4%NZ$2.76NZ$2.22NZ$2.113
Feb ’24NZ$2.35
NZ$2.47
+5.0%
8.6%NZ$2.76NZ$2.27NZ$2.223
Analyst Price Target
Consensus Narrative from 3 Analysts
NZ$2.02
Fair Value
9.9% undervalued intrinsic discount
3
Number of Analysts

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/21 15:42
End of Day Share Price 2025/02/21 00:00
Earnings2024/09/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Vital Healthcare Property Trust is covered by 5 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Joshua DaleDeutsche Bank
Rohan Koreman-SmitForsyth Barr Group Ltd.
Arie DekkerJarden Limited